TrialSite recently learned from a major trial site organization that AstraZeneca’s AZD1222 (Oxford vaccine) Phase 3 trial was on indefinite hold due to the safety incident…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.